Sterlife Biotech Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 2.00 M
- Company Age 7 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.00 M
- Revenue Growth -9.38%
- Profit Growth 71.50%
- Ebitda 15.44%
- Net Worth 62.61%
- Total Assets 0.67%
About Sterlife Biotech
Sterlife Biotech Private Limited (SBPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 October 2017 (Seven years and three months 29 days old ). Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹2.00 M.
Lakhaman Domadiya, Dilipbhai Gordhanbhai, and Bhupat Domadiya serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999GJ2017PTC099570
- Company No.
099570
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Oct 2017
- Date of AGM
15 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Sterlife Biotech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lakhaman Domadiya  | Director | 24-Oct-2017 | Current |
| Dilipbhai Gordhanbhai | Director | 24-Oct-2017 | Current |
| Bhupat Domadiya | Director | 24-Oct-2017 | Current |
Financial Performance of Sterlife Biotech.
Sterlife Biotech Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 9.38% decrease. The company also saw a substantial improvement in profitability, with a 71.5% increase in profit. The company's net worth Soared by an impressive increase of 62.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sterlife Biotech?
Unlock access to Sterlife Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Sterlife Health Care LlpLakhaman Domadiya is a mutual person
Charges (Loans)
₹2.00 M
₹0
Charges Breakdown by Lending Institutions
- Indian Overseas Bank : 0.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Mar 2019 | Indian Overseas Bank | ₹2.00 M | Open |
How Many Employees Work at Sterlife Biotech?
Unlock and access historical data on people associated with Sterlife Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sterlife Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sterlife Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
